中共党员，外科学博士，主治医师，毕业于北京协和医学院。曾获北京市优秀毕业生、北京大学医学部校级优秀住院医师荣誉称号。中国医疗保健国际交流促进会结直肠病学分会秘书。目前主要从事消化道肿瘤的临床与科研工作，主要研究方向为免疫微环境与胃癌淋巴结转移，在Mol Cancer、J Exp Clin Cancer Res、Cancer Lett等国内外知名期刊发表论文及综述30余篇，参加专著和教材编写8部，以第一或共同第一作者发表SCI论文8篇、中文核心期刊论文2篇。主持1项国家自然科学基金青年项目，参与973、国家自然科学基金、北京市自然科学基金等多项国家级省部级课题，多次参与美国外科医师学院(ACS)年会和世界外科大会(WCS)等国际会议进行大会发言和壁报展示。

发表论文

1. Qiu J#, Feng M#, Yang G, Cao Z, Liu Y, You L, Zhang T*. mTOR inhibitor, gemcitabine and PD-L1 antibody blockade combination therapy suppresses pancreatic cancer progression via metabolic reprogramming and immune microenvironment remodeling in Trp53flox/+LSL-KrasG12D/+Pdx-1-Cre murine models. Cancer Lett. 2023; 554: 216020.

2. Feng M#, Wei J#, Ji K#, Zhang Y, Yang H, Wu X, Zhang J, Bu Z*, Ji J*. Characteristics of lymph node stations/basins metastasis and construction and validation of a preoperative combination prediction model that accurately excludes lymph node metastasis in early gastric cancer. Chin J Cancer Res. 2022;34(5):519-532.

3. Liu Y#, Feng M#, Chen H, Yang G, Qiu J, Zhao F, Cao Z, Luo W, Xiao J, You L, Zheng L, Zhang T*. Mechanistic target of rapamycin in the tumor microenvironment and its potential as a therapeutic target for pancreatic cancer. Cancer Lett. 2020, 485: 1-13.

4. Feng M, Xiong G, Cao Z, Yang G, Zheng S, Qiu J, You L, Zheng L, Zhang T*, Zhao Y*. LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer. J Exp Clin Cancer Res. 2018, 37 (1): 274.

5. Xiong G#, Huang H#, Feng M#, Yang G#, Zheng S, You L, Zheng L, Hu Y, Zhang T*, Zhao Y*. MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2018, 37(1):76.

6. Feng M#, Xiong G#, Cao Z#, Yang G, Zheng S, Song X, You L, Zheng L, Zhang T*, Zhao Y*. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Lett. 2017, 407: 57-65.

7. Xiong G#, Feng M#, Yang G#, Zheng S, Song X, Cao Z, You L, Zheng L, Hu Y, Zhang T*, Zhao Y*. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer. Cancer Lett. 2017, 397: 94-102.

8. Feng M#, Cao Z#, Sun Z, Zhang T*, Zhao Y*. Pancreatic head cancer: Open or minimally invasive pancreaticoduodenectomy? Chin J Cancer Res. 2019;31(6):862-877.

9. 冯梦宇，张太平*，赵玉沛，加速康复外科在胰腺外科中的应用现状和展望，浙江大学学报(医学版)，2017, 46(6): 666-674.

10. 冯梦宇，张太平*，赵玉沛.自身免疫性胰腺炎和胰腺肿瘤鉴别诊断的进展与争议.中华肝脏外科手术学电子杂志，2019，8(3)：179-182.